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INTRODUCTION
T cells and B cells constitute the primary recognition and
response cells of the vertebrate adaptive immune system. These
cells, like all other vertebrate blood cells, develop from
hematopoietic stem cells. The branching pathways of
lymphocyte development (Fig. 1) involve multiple cell fate
determination steps, which include the loss of developmental
potential for certain lineages as well as commitment to specific
lineages including T cells, B cells and natural killer (NK) cells.
There are several unique advantages to using lymphocyte
development as a model for cell fate determination. Many
successive stages of T cell and B cell development can be
precisely identified and isolated on the basis of their expression
of unique combinations of cell surface markers, allowing very
fine scale analysis of gene expression patterns at each stage.
Furthermore, because the developmental programs for these
cells include the progressive rearrangement of gene segments
encoding the B cell or T cell receptors for antigen (Ig and TCR,
respectively), the order of the later stages can be established
unequivocally by reference to these irreversible DNA alterations.
Finally, cell transfer and in vitro differentiation experiments
using lymphocyte precursor populations have provided detailed
evidence for the developmental potential of each stage. These
studies have identified common lymphoid progenitors (CLP) in
the bone marrow (Kondo et al., 1997) and among the most
primitive cells in the thymus (Wu et al., 1996; Carlyle et al.,
1997). In the thymus, such multipotent progenitors undergo a
stepwise narrowing of developmental potential, first apparently
losing the ability to become B cells, then the potential to become
NK cells, and finally the potential to become thymic dendritic
cells (DC), thus resulting in commitment to the T lineage
(reviewed in Shortman and Wu, 1996; Zúñiga-Pflücker and
Lenardo, 1996). We have exploited the ability to isolate cells that
are at known stages in the course of this segregation of
developmental potentials (Fig. 1) to identify transcription factors
that may be involved in cell fate determination in this system. 
In spite of the detailed studies available on developmental
potential and differentiation stages of lymphocyte maturation,
the molecular mechanisms of commitment to the T and B cell
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Ets family transcription factors control the expression of a
large number of genes in hematopoietic cells. Here we show
strikingly precise differential expression of a subset of these
genes marking critical, early stages of mouse lymphocyte
cell-type specification. Initially, the Ets family member
factor Erg was identified during an arrayed cDNA library
screen for genes encoding transcription factors expressed
specifically during T cell lineage commitment.
Multiparameter fluorescence-activated cell sorting for over
a dozen cell surface markers was used to isolate 18 distinct
primary-cell populations representing discrete T cell and
B cell developmental stages, pluripotent lymphoid
precursors, immature NK-like cells and myeloid
hematopoietic cells. These populations were monitored for
mRNA expression of the Erg, Ets-1, Ets-2, Fli-1, Tel, Elf-1,
GABPa , PU.1 and Spi-B genes. The earliest stages in T cell
differentiation show particularly dynamic Ets family
gene regulation, with sharp transitions in expression
correlating with specification and commitment events. Ets,
Spi-B and PU.1 are expressed in these stages but not by
later T-lineage cells. Erg is induced during T-lineage
specification and then silenced permanently, after
commitment, at the b -selection checkpoint. Spi-B is
transiently upregulated during commitment and then
silenced at the same stage as Erg. T-lineage commitment
itself is marked by repression of PU.1, a factor that
regulates B-cell and myeloid genes. These results show that
the set of Ets factors mobilized during T-lineage
specification and commitment is different from the set
that maintains T cell gene expression during thymocyte
repertoire selection and in all classes of mature T cells.
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lineages remain elusive. Our studies are designed to address
the following questions. (1) Which transcription factors are
involved in the loss of alternative developmental potentials
and/or positive specification to the lymphoid lineages? (2) How
do these factors differ between B and T cell developmental
lineages, which employ parallel but distinct molecular
differentiation events? To some extent we can deduce the gene
families to which the critical transcription factors belong by
examining the cis-regulatory sequences of lineage-specific
genes. However, factors implicated in lymphoid gene
expression are often members of multigene families composed
of highly related members; although many of these have
similar DNA binding specificities, they may differ in their
interactions with other factors and with cellular signaling
pathways that affect their transcriptional activity. Therefore,
analysis of the specific family members that are present at each
developmental stage is needed to provide a framework for
designing experiments to determine the molecular mechanisms
of lymphocyte fate determination.
In these studies we present evidence that nine different
transcription factors of the Ets family are expressed in early
thymic precursors, and that the majority of these are under
lineage- and developmental stage-specific regulation. The Ets
family has ancient metazoan origins (Degnan et al., 1993) and
its members play critical roles in the development of many
different organisms (Lai et al., 1997; Morimoto et al., 1996; Wei
et al., 1995; Tan et al., 1998). Here we find that subsets of Ets
factors are silenced as lymphoid development progresses, while
other subsets are maintained or upregulated in lineage-specific
combinations. PU.1, which is essential for development of B
cells and macrophages (Scott et al., 1994; McKercher et al.,
1996), is expressed in the earliest lymphoid precursors and
silenced when they undergo commitment to the T lineage. Erg,
a factor that had not been associated with T cell development
previously, is sharply induced at the time of T-lineage
specification and shut off once T-lineage commitment is
complete. The complexity of the pattern of Ets family expression
is unexpected, since both T and B cells express many cell-type
specific genes throughout their development that have simply
been regarded as regulatory targets of the common Ets factor,
Ets-1. Our data raise the possibility that other Ets family factors
with distinctive biochemical properties may in fact control the
regulation of Ets target genes at certain stages of lymphoid
development. 
MATERIALS AND METHODS
Animals
The animals used in this study were C57BL/6 (B6) mice, (B6,129)-
Rag-2 - / - mice, C.B-17 SCID mice, B6-b 2m- /- I-A b - / - (B6 MHC- /- )
mice and B6 SCID mice. Thymus samples were taken from animals
3-5 weeks old, while splenic and bone marrow samples were taken
from animals older than 10 weeks. Most of the animals used were
bred and maintained under sterile conditions at Caltech. For large
experiments, C.B-17 SCID and B6.SJL-ptprca-Rag-2 - /- mice were
obtained from Taconic (Germantown, NY). 
RNA extraction and first strand cDNA synthesis
RNA was extracted using the RNAzol B reagent (Leedo Medical Inc.,
Houston, TX), according to manufacturer’s directions. Poly(A)+ RNA
was isolated using Dynal Oligo-T magnetic beads (Dynal, Inc., Oslo,
Norway). Sorted cell samples of 20,000-600,000 cells were lysed in 0.5
ml RNAzol B, and treated as above, adding 20 m g of glycogen during
the isopropanol precipitation step. After heat-denaturation, the RNA
was treated with RNase-free DNase to remove residual genomic DNA.
First strand cDNA was generated from total RNA using Superscript RT
II (Gibco/BRL, Gaithersburg, MD) and random hexamers (250 ng)
according to manufacturer’s directions. After first strand synthesis, the
cDNA was treated with RNase H for 30 minutes at 37°C. 
Degenerate PCR 
PCR primers were designed to complement regions of conserved
amino acids in the DNA binding domains of different transcription
factor family members as follows:
5¢ ETS-WQFL: CAGTCGACTGGCA(A/G)TT(T/C)(T/C)T
3¢ ETS-MNDYK:
CAGCGGCCGCTT(A/G)TC(A/G)TA(G/A)TTCAT
3¢ ETS-MTDYK: CAGCGGCCGCTT(A/G)TC(A/G)TANGTCAT
5¢ BHLH-ANNA: CCAAGCTTAGCNAA(T/C)AA(T/C)GC
5¢ BHLH-DINEA:
CCAAGCTTCGA(T/C)AT(T/C/A)AA(T/C)GA(A/G)GC
3¢ BHLH-NPKA: CCTCTAGAGC(T/C)TTNGG(A/G)TT
5¢ GATA-CVNC: CAGCGGCCGCTG(T/C)GTNAA(T/C)TG
5¢ GATA-TGHY: CAGCGGCCGCACNGGNCA(T/C)TA
3¢ GATA-NACG: CAGTCGACCC(A/C)CANGC(A/G)TT
5¢ HOX-YPWM: CAGTCGACTA(T/C)CCNTGGATG
3¢ HOX-WFQN: CAGCGGCCGCTT(T/C)TG(A/G)AACCA
5¢ PAX-PCDI: CAGCGGCCGCCCNTG(T/C)GA(T/C)AT
3¢ PAX-WEIR: CAGCGGCCGC(G/T)(A/G)AT(T/C)TCCCA
5¢ POU-EQFA: CAGCGGCCGCGA(A/G)CA(A/G)TT(T/C)GC
3¢ POU-NMCK: CAGTCGACTT(A/G)CACAT(A/G)TT
PCR reactions were conducted in 50 m l total volume reactions,
consisting of 5% of a first strand C.B-17 SCID thymocyte cDNA
reaction, 1· PCR Buffer II (10 mM Tris pH 8.3, 50 mM KCl), 2 mM
MgCl2, 0.2 mM dNTPs, 250 ng of each degenerate primer and 2.5
units of AmplitaqGOLD (Applied Biosystems, Foster City, CA). The
AmplitaqGOLD was activated by an initial 8 minute incubation at
95° C, followed by 35 cycles: 95° C for 1 minute, 45 ° C for 1 minute,
72° C for 1 minute. PCR products were resolved on 4% agarose gels.
Bands of the appropriate sizes were cored, diluted in 1· TE (10 mM
Tris pH 8.0, 1 mM EDTA) and reamplified using the same primers,
for 25 cycles with a 55 ° C annealing step. Reamplified products were
subcloned into the plasmid vector pSPORT1. Individual clones were
picked and DNA was extracted using Qiagen spin miniprep kits
(Qiagen, Chatsworth, CA). The DNA samples were sequenced,
analyzed and used as probes to iteratively screen other recombinants
to find multiple family members from the same bands.
cDNA library screening
A C.B-17 SCID thymocyte random-primed cDNA library was
constructed in the pSPORT1 vector (Gibco/BRL), and was arrayed
and spotted at high density onto Hybond-N+ nylon filters (Amersham,
Little Chalfont, Buckinghamshire, UK) using the Q-Bot robot
(Genetix, Christchurch, Dorset, UK). Radiolabeled DNA probes were
produced by standard random-prime labeling methods using [ a -
32P]dCTP. The library filters were prehybridized for 1-2 hours in
hybridization buffer (5 · SSPE (0.75 M NaCl, 50 mM NaH2PO4,
5 mM EDTA, pH 7.4)/5 · Denhardts/0.5%SDS/0.05%Na4P7O2)
containing 5 mg heat-denatured sheared salmon sperm DNA.
Hybridizations were at 65 ° C for 16-24 hours, followed by 52 ° C
washes with 2 · SSPE/0.1% SDS/0.05% Na4P7O2 for low stringency
screening. 
Differential screening of subarray
DNA samples (100 ng) extracted from cDNA plasmid clones were
denatured in 0.4 M NaOH/10 mM EDTA, pH 8.2, heated to 95° C for
10 minutes and spotted onto Hybond-N+ nylon membranes using a
M. K. Anderson and others
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Dot Blot Manifold apparatus (Schleicher and Schuell, Keene, NH).
The samples were applied to the membranes under vacuum, followed
by 500 m l of 0.4 M NaOH per well. Membranes were rinsed with 2 ·
SSC and air dried. To generate tissue-specific probes, 1 m g of poly(A)+
RNA from C.B-17 SCID thymocytes, B6 spleen or B6 liver was
reverse-transcribed using Superscript RT II and random hexamers, in
the presence of 250 m Ci [ a -32P]dCTP. This procedure generated an
average of 350 ng of cDNA probe labeled to a specific activity of
3· 108 cpm/ml, in a total volume of 100 m l. Probes were hybridized
with the filters as above, for 40-48 hours at 65 ° C, and washed under
high stringency conditions at 65° C with 0.1· SSPE/0.1%SDS/
0.05%Na4P7O2. 
Cell sorting
Splenocytes, thymocytes, or bone marrow cells were obtained from
animals immediately after killing. Cells were incubated in CBSS (5.4
mM KCl, 0.3 mM Na2HPO4, 0.4 mM KH2PO4, 4.2 mM NaHCO3,
137 mM NaCl, 5.6 mM D-glucose pH 7.4)/1%BSA with clone 2.4G2
anti-CD32/CD16 (Fc g RIII/II) supernatant on ice for 10 minutes,
followed by addition of antibodies for staining. Cells stained with
biotin-conjugated antibodies were washed with CBSS/1%BSA before
staining with Streptavidin-Red670 (Gibco). Stained cells were sorted
using a Coulter Epics Fluorescence-activated cell sorter (Coulter
Electronics, Hialeah, FL). All sorted fractions were reanalyzed
immediately for purity, and all fractions used here were at least 97%
pure, with the exceptions of populations ‘1a’ (91%) and ‘15’ (96%).
Complete data for purity are given in the legend to Table 2.
All of the antibodies used in this study were obtained from
Pharmingen (San Diego, CA) unless otherwise indicated. Rag-2- / -
thymocytes were stained with Sca-1-biotin, CD44-PE and
HSA(CD24)-FITC. Sorting of the CD4 (CD4+CD8- CD3+) and CD8
(CD4- CD8+CD3+) single positive thymocytes, the B6 double negative
thymocytes (CD4- CD8- CD3- ), and the intermediate single positive
thymocytes (CD4- CD8+CD3 - ) was done in two separate batches after
pre-enrichment by depletion of either CD4+ or CD8+ cells using CD4-
biotin or CD8-biotin with avidin-coupled magnetic beads on a MACS
column (Miltenyi Biotec, Auburn, CA). After enrichment, the cells
were stained with CD4-PE (Becton-Dickinson, Mountain View, CA),
CD8-FITC (Becton-Dickinson) and CD3-670QR (Sigma, St Louis,
MO). The double positive thymocytes (CD4+CD8+TCRb lo) were
sorted from B6 MHC - /- or B6 mice without pre-enrichment after
staining with CD8-FITC, CD4-PE and TCR b -T/C. 
To obtain the fetal ab and gd T cell subsets, thymuses from B6 E14
mice were cultured as described (Jenkinson and Owen, 1990) for 13
days. The thymuses were stained with TCR b -PE and TCR gd -FITC,
and sorted as above. For peripheral T cells, splenocytes were pre-
enriched for T cells by incubation with B220-biotin and avidin-
magnetic beads followed by passage over a MACS column. Pre-
enriched cells were sorted after staining with CD8-FITC, CD4-PE and
TCR b -T/C (Caltag, So. San Francisco, CA). CD4+CD8- TCRb + and
CD4- CD8+TCR b + subsets were collected. B220+TCRb - splenocytes
were collected after staining with B220-FITC and TCRb -T/C, without
pre-enrichment.
B6 SCID bone marrow, Rag-2 - /- bone marrow and B6 bone marrow
were used as sources of B cell developmental subsets. The SCID and
Rag-2 - /- bone marrow cells were stained with CD19-biotin, CD43-
PE and B220-FITC. The B6 bone marrow was stained with B220-Cy
and IgM-FITC and the B220+IgM- and B220+IgM+ subsets were
collected. B6 bone marrow was also stained with Gr-1-FITC and Mac-
1-FITC, and the FITC+ fraction was collected as a source of myeloid
lineage cells.
Gene-specific PCR
Primers for gene-specific PCR were designed to discriminate between
family members without cross-reactivity. Most primer sets cross exon
boundaries. HPRT primers were used to amplify products from
serially diluted cDNA samples to achieve normalized samples. PCR
parameters for the HPRT reaction (25 m l total volume) were: 8
minutes 95° C, followed by 32-35 cycles at 95° C for 45 seconds, 65 ° C
for 45 seconds, 72 ° C for 45 seconds in an MJ PTC-200 DNA Engine
Thermal Cycler (MJ Research, Inc., Watertown, MA). All primers,
listed in Table 1, were used at a final concentration of 0.4 m M each.
The mb-1 primers (Wang et al., 1998a) were kindly provided by Hua
Wang. cDNA samples were normalized according to HPRT levels by
dilution in 1 · TE. On average, a 1/50 dilution was made from a 20
m l cDNA sample representing 50,000 sorted cells, and 1-3 m l of the
1/50 dilution were used per PCR reaction, resulting in an average of
cDNA from 50-150 cells being amplified per reaction. Primers
specific for divergent regions of Ets family members or the PIP gene
(Table 1) were used to amplify products from normalized diluted
cDNA samples. Reactions were as for HPRT, with the exception of a
60° C annealing temperature and a range of 32-40 cycles, depending
on the primer set. 
No major differences in product distribution were observed
between different primer sets used to amplify different portions of the
Erg, PU.1 or Ets-1 genes (data not shown). The primer sets referred
to here as Spi-B1 (I) and Spi-B2 (II) are specific for the two different
promoters used by Spi-B (Chen et al., 1998). The multiple bands
represent isoforms of Spi-B according to hybridization to Spi-B
specific probes, but they do not correspond in size to the splice
isoforms previously reported (Ray-Gallet et al., 1996).
RNA gel blots
Total RNA was electrophoresed on denaturing agarose gels containing
5% formaldehyde. The gels were blotted onto Hybond-N+ membranes
by downward alkaline transfer in 50 mM NaOH as described
(Ingelbrecht et al., 1998). Hybridization to random-primed probes was
performed as described above.
Sequencing
Sequencing was performed using the ABI Prism Dye Terminator
Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Foster City,
CA). Sequence analysis was performed using the DNASIS software
package (Hitachi Software, Inc., San Francisco, CA).
RESULTS
A strategy for identification of transcription factors
involved in lymphocyte lineage determination
The initial objective of this work was to identify transcription
factors that might play important roles in the mechanism of
commitment to the T cell lineage. cDNA clones encoding
such factors should be enriched in cDNA libraries made
specifically from cells undergoing the commitment process.
The thymuses of immune-deficient SCID and Rag-2 - / - mice
contain only the earliest developmental subsets of
thymocytes, and are highly enriched for multipotent
progenitors and their progeny undergoing divergence into the
natural killer (NK), dendritic cell (DC) and T cell lineages.
As many as 15-20% of the cells at steady state in the SCID
thymus, for example, appear not to have undergone complete
commitment to the T cell lineage yet (Diamond et al., 1997;
Shortman and Wu, 1996; Wu et al., 1996). The thymus
populations of these mutant mice thus offer access to the
molecular biology of several steps of lymphocyte
developmental choice (see Fig. 1).
A three-step strategy was designed to identify cDNA clones
from SCID thymocytes that encode transcription factors
expressed at the right time to serve developmental roles. First,
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a degenerate-primer RT-PCR approach was used to amplify
sequences expressed in SCID thymocyte RNA that encode
conserved transcription factor domain motifs. The sequences
of these amplified products provided one source of expression
data. Second, a cDNA library was constructed from SCID
thymocyte poly(A)+ RNA, and robotically arrayed for
archiving and high-density filter screening. Mixtures of unique,
ampified sequences generated by degenerate-primer RT-PCR
were used as probes to identify putative transcription factor
clones in the library. Finally, clones from the cDNA library that
M. K. Anderson and others
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Fig. 1. Developmental potential and
progression of lymphoid progenitors. This
figure shows the developmental
progression of the cell types sorted and
analyzed for Ets factor expression at the
mRNA level in this study. The numbering
and color scheme used in this figure are
consistent throughout this paper.
Populations which occur in the thymus,
bone marrow (BM) or spleen are
designated in the upper lefthand oval, the
lower lefthand oval, or the righthand oval,
respectively, as indicated by the italicized
labels. Hematopoietic stem cells (HSC)
and BM-derived common lymphoid
progenitors (CLP) were not collected but
are included in this figure to show their
developmental relationships with the other
populations. Detailed phenotypes of all of
the populations analyzed in this study are
listed in Table 2. White circles indicate
multipotent progenitors. Striped circles
indicate specification towards specific
lineages prior to actual commitment.
Specification is defined here as the
upregulation of lineage-specific genes,
while commitment is defined as the loss of
developmental potential to become any
other cell type. Solid lines indicate well-
defined differentiation pathways, dashed lines indicate possible differentiation pathways, and dotted lines indicate a low (measured) probability
of differentiation along that pathway. Rag-2- /- and SCID mice, which cannot rearrange either the immunoglobulin (Ig) or T cell receptor (TCR)
genes, contain only the lymphoid populations to the left of the thick black vertical line, while normal mice contain all of the lymphoid
populations depicted here. HSCs can differentiate either towards the lymphoid lineages, resulting in common lymphoid progenitors (CLPs; not
included in this study), or towards the erythroid and/or myeloid lineages (population 16=mixed myeloid lineage cells). The CLP retains the
potential to develop into any of the classical lymphoid lineages, including T cells, B cells and natural killer (NK) cells, as well as thymic
dendritic cells (DC), but not any of the myeloid or erythroid cell types. The CLP or its progeny may differentiate towards the B cell lineage in
the bone marrow (pre-pro-B; not collected) or migrate to the thymus (populations 0 and/or 1). The pre-pro-B cells express some B lineage-
specific genes such as B220 but are not yet committed, and retain the potential to develop in the bone marrow into NK cells (Rolink et al.,
1996). The pro-B cells (population 13) have not yet rearranged their Ig heavy or light chain genes, but are believed to be committed to the B
cell lineage (Hunte et al., 1998). Some of these cells also are contained in population 14 (pre-B cells) because of the criteria for selection (see
Table 2). The bulk of the cells in population 14, however, are pre-B cells which have rearranged their Ig heavy chains and express cytoplasmic
m chains but do not yet express the pre-B cell receptor (pre-BCR), composed of the IgM heavy chain and the surrogate light chains l 5 and
VpreB, on the cell surface. Rearrangement and expression of an Ig light chain locus results in expression of membrane-bound IgH-IgL
heterodimers and B cell maturation. Population 15 contains primarily cells which express the mature BCR, and are likely a combination of
immature and mature B cells, with a preponderance of the latter. Mature B cells transit to the peripheral organs, including the spleen, where
they may undergo class switching; therefore, the splenic B cells collected here (population 17) likely contain a mixture of B cell expressing
different isotypes, of which most are IgM-bearing B cells. The progeny of the HSC or CLP that transit to the thymus are probably contained
within the thymic progenitor populations represented by populations 0 and 1. They can either differentiate towards the NK cell lineage
(population 2) or the T cell lineage (population 3). Pro-T1 cells retain the ability, although decreased compared with that of the thymic
progenitors, to become an NK cell or a thymic DC, while pro-T2 cells (population 4) are committed to the T lineage. Pro-T2 cells either
rearrange their TCRb chains or their TCR g chains. Successful rearrangement and expression of both TCR g and TCRd chains results in the
production of gd T cells. The majority of these cells are produced in specific waves in the fetal mouse thymus, and population 12 examined here
is of fetal origin. However, both ab and gd T cells are produced in the thymus (with a much higher ratio of ab T cells to gd T cells) postnatally
and throughout the lifetime of the animal. Both fetal and adult gd T cells differentiate from pro-T cells which are already committed to the T
lineage, represented here by the pro-T2 stage (population 4). All subsequent stages of T cell development examined here progress towards the
ab T cell lineages. Pre-T cells (immature single positive CD8+ cells: ISP; population 5) have successfully rearranged the TCRb chain and
express the pre-TCR composed of TCRb and pre-T- a . Successful TCRa chain rearrangement and expression results in cell surface expression
of the TCR ab heterodimer (Double positive CD4+ CD8+ cells: DP; population 6). These pre-T cells are subjected to both positive and negative
selection before maturing into either CD8+ (killer) single positive (SP) T cells (population 7) or CD4+ (helper) SP T cells in the thymus. These
cells migrate into the peripheral lymphoid organs including the spleen (populations 9 and 10).
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hybridized with these transcription factor domain probes were
subarrayed and screened with total cDNAs from distinct tissues
to identify factors of particular developmental interest. This
paper reports one striking aspect of the findings that emerged
from this program. 
Differential expression analysis: Erg and HEB
transcripts specifically enriched in early thymocytes 
To achieve the first aim described above, degenerate PCR
primers complementing conserved amino acids of the DNA
binding domains of the Ets, Class A bHLH, GATA, POU, Hox
and Pax families were used to amplify products from SCID
thymocyte first strand cDNA. Appropriately sized bands were
cloned and multiple clones were sequenced. Clones were
iteratively screened to be certain that all different PCR products
contained within a band were detected. The Ets PCR primers
amplified four known Ets family members: Erg, ERM, Elk-1
and ERP. The Class A bHLH family primers amplified all three
known family members (E2A, HEB and E2-2, using the human
nomenclature). The GATA primers amplified GATA-3, the
POU primers amplified Oct-1 and EMB and the Pax primers
amplified Pax-1 and Pax-9. The Hox primers amplified Hox-
B4. These PCR products were pooled and used to screen the
arrayed SCID thymocyte cDNA library (70,000 clones) at low
stringency in order to detect all related cDNAs. Clones
hybridizing at various intensities were isolated and partially
characterized. The Ets family member clones were: Fli-1 (2
clones), ERP (2 clones) and Erg (1 clone). Other clones
retrieved from the library included GATA-3 (1 clone), E2A (2
clones), Pax-1 (2 clones), HEB (2 clones) and Oct-1 (2 clones). 
To analyze the tissue distribution of these clones, plasmid
DNA was extracted from each of the clones which had
hybridized with the pooled transcription factor probes. These
DNA samples were subarrayed in a dot blot format onto three
triplicate nylon membranes for differential screening (Fig. 2).
Each subarray was hybridized to radiolabeled first strand
cDNAs from SCID thymocytes, spleen and liver. The SCID
thymocyte cDNA probe was used to generate an immature
thymocyte expression profile, and the liver cDNA probe was
used to identify and exclude nonlymphoid-specific genes. To
identify genes used specifically in early lymphoid lineage
divergence events, a spleen cDNA probe was also used to
exclude genes expressed at high levels in mature lymphocytes.
This type of differential screen allows the comparison of the
relative expression levels of a large number of genes at the
same time, in that the differences in the intensity of the spots
should correspond to the prevalence of those transcripts in each
respective tissue type. Spot intensity was compared, and three
clones were chosen for further analysis based on more intense
hybridization to the SCID thymocyte probe than to the spleen
or liver probes (Fig. 2). Sequencing revealed that one of these
clones encodes a portion of the Ets family member Erg, and
the other two encode portions of the bHLH family member
HEB. 
The finding that Erg is expressed at higher levels in SCID
thymocytes than in the spleen was surprising, in part because
Erg has been implicated in B cell but not T cell gene expression
(Rivera et al., 1993), and in part because Ets-1 and Elf-1 are
the Ets family members that have been predominantly
associated with T cell development and function in previous
studies (Muthusamy et al., 1995; Bories et al., 1995; Ernst et
al., 1996). One essential question arising from this finding was
whether the cells expressing Erg in the SCID thymus are T cell
precursors, nonlymphoid thymic stromal cells, or lymphocytes
of another lineage. If indeed Erg is expressed by T cell
precursors, it also raises the important question of when its
expression is shut off. Between the SCID arrest point and the
arrival of mature T cells in the periphery lie the most intensely
studied events that occur in thymocyte differentiation: the
stages when cell fate is determined by T cell receptor
interactions with the environment, and positive and negative
selection events shape the antigen-recognition repertoire of the
T cell population as a whole. The second essential question is
therefore whether the expression of Erg is extinguished during
the early, antigen receptor-independent phase of thymocyte
development, or in a later, antigen receptor-dependent
transition. In order to confirm the differential expression
analysis results and address these questions, RT-PCR was
conducted on first strand cDNA samples derived from highly
defined, sorted, thymic, splenic and bone marrow cell
populations, as described below. 
System for analysis of Ets family gene regulation
relative to landmarks in lymphocyte development
Early stages in lymphocyte development cannot be
distinguished by spatial and/or temporal coordinates, nor by
morphology, so that in situ hybridization methods are
inadequate to define developmental gene expression programs.
Table 1. Gene-specific PCR primers for RT-PCR analysis
of sorted developmentally staged lymphocyte populations
Gene Primers and probe Product size (bp)
HPRT S-CCAGCAAGCTTGCAACCTTAACCA 176
A-GTAATGATCAGTCAACGGGGGAC
ETS-1 S-CTACGGTATCGAGCATGCTCAGTG 192
A-AAGGTGTCTGTCTGGAGAGGGTCC
ETS-2 S-ACTCTCACCTCAACGCGGTTCCTC 249
A-GGAAGTCCTGGCTGATGGAACAGT
FLI-1 S-CCAGAACATGGATGGCAAGGA 303
A-CCCGGAATCTGATAAGGATCTGGC
ERG (I) S-CAGCGGCTCACGCCGAGCTACAAT 284, 214
(II) S-CAGTATATCCCGAAGCTACGC 108
A-TTTGGACTGAGGGGTGAGGTGGCT
PU.1 S-ATGGAAGGGTTTTCCCTCACCGCC 216
A-GTCCACGCTCTGCAGCTCTGTGAA
SPI-B1 (I) S-CATGCTTGCTCTGGAGGCTGCACA 261
SPI-B2 (II) S-CCTGACATGCCCCTGTGTCTCT 269
SPI-B* A-AGCAGGATCGAAGGCTTCATAGGG
ELF-1 S-ACAGTGCCACTCACAACGGT 240
A-CGCTCCATTGCAAATGGACTG
TEL S-ACTCTATCCACACCAAGCCAG 242
A-GGCTTTCTCCACTGGCGAGA
GABP a S-CTTGGCATCCCCTATGATCCT 258
A-CATCTGTTGCTCTTGGCTGGC
PIP S-TGAGAAGTTGCTGAGCCACCT 372
A-GTATCGTGTTCAGGTAACTCG
A, antisense; S, sense.
*Antisense primer used with either sense primer for splice isoform
amplification.
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However, ample tools are available to trace cells through this
process. We used over a dozen cell-surface markers for
fluorescence-activated cell sorting and took advantage of
targeted mutations that block lymphocyte development at
defined points to isolate 18 different cell populations (pops)
representing known stages in lymphocyte development.
Populations of lymphocyte precursors for which
developmental potentials have been determined by cell transfer
and in vitro differentiation studies are shown schematically in
Fig. 1 and discussed in detail in the legend to Fig. 1 (Rolink et
al., 1996; Li et al., 1996; Kondo et al., 1997; Wu et al., 1996;
Carlyle et al., 1997; Shortman and Wu, 1996). Although
specification and commitment to the T cell and B cell lineages
are accompanied by the beginning of TCR and Ig gene
rearrangement, respectively, it is also possible to distinguish
‘pro-T’ and ‘pro-B’ cell stages prior to rearrangement when
the cells have instituted T- and B-cell specific gene expression
programs (Li et al., 1993, 1996; Wang et al., 1998a,b).
Therefore, the pro-T (pops 3, 4) and pro-B (pop. 13) cells
isolated in this study have undergone specification even if they
are not yet irreversibly committed to the T or B cell lineage.
After commitment to the T cell lineage, another developmental
choice occurs: the ab (pop. 11, fetal) versus the gd (pop. 12,
fetal) T cell lineage. Cells which successfully rearrange the
TCR g and d chain genes follow an alternative route to
becoming mature gd T cells, while those expressing the TCR
b chain encounter the first developmental checkpoint ( b
selection) along the primary path of T cell development
towards the ab T cell lineage. The b selection checkpoint is so
called because only cells which successfully express the TCR
b -chain in the pre-TCR complex can survive and proliferate
thereafter. Cells that cannot carry out rearrangement at all, e.g.
in the SCID and Rag-2 - /- mutants, arrest their development at
this point (pop. 0-4). 
After b -selection, thymocytes acquire the CD4 and CD8
markers and go through a transitional intermediate (ISP, pop.
5) to become ‘double positive’ (DP, pop. 6). After the second
checkpoint, when the cells are tested for TCR recognition
specificity, they lose either CD4 or CD8 and become ‘single
positive’ (SP, pops 7, 8). This transition involves yet another
developmental choice: the choice to become an SP helper
(CD4+) cell (pop. 8) or an SP killer (CD8+) cell (pop. 7). At
each checkpoint, cells that fail die and the cells that succeed
move to the next stage of maturation. Successful transit
through each checkpoint is followed by sharp changes in cell-
cycle status and functional activity (Rothenberg et al., 1994;
Hoffman et al., 1996; Rincon and Flavell, 1996). The cells then
leave the thymus to function in the periphery as mature T cells
(including pops 9 and 10). B cells undergo a similar sequence
of developmental checkpoints (see Fig. 1), although
conventional B cell progenitors may not have choices
analogous to the TCR ab /gd or helper/killer split. 
Populations representing the earliest stages of T-cell
development have been studied intensively by our laboratory
and the laboratories of others. The changes in developmental
potential indicated in Fig. 1 have been robustly associated with
phenotypic landmarks (reviewed by Shortman and Wu, 1996;
Zúñiga-Pflücker and Lenardo, 1996; Rothenberg et al., 1999),
and these criteria have been used to define the populations we
compare in the present work. Furthermore, our own previous
RT-PCR analyses of populations 1-4 (Wang et al., 1998a,b)
have shown that these subsets express dramatically distinct,
reproducible patterns of T and non-T lineage associated genes.
Each pattern is characteristic of the cell type regardless of the
mouse strain from which it is isolated. Thus, cell sorting and
RT-PCR analysis under the conditions used here are
sufficiently sensitive and quantitative to define changes in gene
regulation that correlate with key transitions in lymphocyte
development.
The range of populations analyzed in this study (Table 2)
allows us to distinguish potential roles for Erg and other Ets
family members in specification to the T lineage from potential
roles in cell cycle control, susceptibility to apoptosis, helper
versus killer function, or activation status. To establish the
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Fig. 2. Differential screening of SCID thymocyte cDNA subarray.
DNA extracted from SCID thymocyte cDNA clones, which
hybridized at low stringency to a mixed batch of probes for BHLH,
ETS, GATA, HOX, PAX and POU transcription factor family
members, was arrayed on three identical nylon membranes. The
three membranes were probed at high stringency: the top membrane
with radiolabeled cDNA from SCID thymocytes, the middle
membrane with radiolabeled cDNA from liver, and the bottom
membrane with radiolabeled cDNA from spleen. Hybridization
intensities are indicative of relative abundance of the message
complementing each clone in each tissue. The membranes were
exposed to film and phosphorimager screens for varied amounts of
time; this figure represents a 3-day exposure to a phosphorimager
screen. Several of the clones were sequenced; many of the sequences
were not clearly related to any other sequences in GenBank. The
clones at the following coordinates were identified by sequence
analysis to be: 1A, Wiskott-Aldrich protein; 1C, Pax-1; 2B, Erg
(denoted by leftward slanted arrow); 2E, E2A; 3D, GATA-3; 3E,
Oct-1; 3F, Erp; 4F, HEB (also known as Alf-1 or ME-1, and denoted
by rightward slanted arrow); 5F, Pax-1; 6E, Erp; 6F, E2A; 7A, g -
catenin; 7D, Fli-1; 8E, Fli-1; 9B, triose phosphate isomerase; 10B,
HEB (denoted by rightward slanted arrow).
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Table 2. Descriptions of the cell populations isolated and examined in this study
Phenotype
Population number Name Tissue* Sorted‡ Additional Proposed developmental significance
0 Precursor SCID Sca-1 - CD25 - Potentially most enriched source of earliest common lymphoid precursors in
thymus HSA- CD44+ thymus that retain potential for T, B, NK and DC lineages: but not fully 
Thy-1- c-kit+ characterized. 
Sca-1–>+
1 Precursor Rag-2 - / - Sca-1+ CD25 - Thymic lymphoid progenitor which is likely to retain potential for T, NK, DC 
thymus HSA- CD44+ and maybe B lineages. Unrearranged TCR genes, no Rag-1 expression.
c-kit+
Thy-1+>-
1a Prexcursor Rag-2 - / - Sca-1+/int CD25 - Mixture of pop.1 precursors and cells in transit to pop.3 pro-T cells; gene 
thymus HSA- /int CD44+ expression patterns link these cells more closely to pop.3 than pop.1.
c-kit+
2 Pre-NK Rag-2 - / - Sca-1 - CD44+ Immature NK cell precursors; commitment status unknown. Expressing
thymus HSA- c-kit+ perforin, IL-2 and IL7Ra mRNAs. Includes small percentage of precursors
NK1.1+ from pop. 0 unless selected for Thy-1 expression (see pop. 2a).
CD122+
2a Pre-NK SCID Sca-1 - CD44+ Immature NK precursors purified away from other lymphoid precursors; 
thymus HSA- c-kit+ commitment status unknown.
Thy-1+ NK1.1+
CD122+
3 Pro-T1 Rag-2- /- /SCID Sca-1+ CD25+ Pro-T cells specified but not yet committed to the T lineage; retain reduced
thymus HSA+ c-kit+ potential for NK and DC lineages. Expressing Rag-1, CD3- e , TdT, pre-T a
CD44+ mRNAs. Normal pro-T1 cells begin TCRb (or TCR g ) rearrangement; 
Rag-2 - / - cells cannot begin rearrangements, SCID cells cannot finish them. 
Enriched for proliferating cells.
4 Pro-T2 Rag-2 - / - Sca-1+ CD25+ Pro-T cells committed to the T lineage, undergoing TCRb or TCRg rearrange-
thymus HSA+ c-kit- ments normally, noncycling until after b selection, die if rearrangements are
CD44- unsuccessful. In Rag-2 - / - thymus, none can survive past this point.
5 ISP pre-T thymus CD8+ CD25 - Intermediate ‘single positive’ pre-T cell, has passed b selection, undergoing
CD3- TCR ab - proliferative burst, begins to rearrange TCRa chains.
CD4-
6 DP pre-T MHC - /- CD8+ Committed pre-T cell, ‘double positive’ because of CD4 and CD8 expression; 
thymus CD4+ TCRb is rearranged and TCRa is undergoing rearrangement; this population 
TCRab lo normally undergoes negative and positive selection but cannot do either in
genetic background that lacks MHC expression, thus remains homogeneous.
7 CD8-SP thymus CD4- TCR ab + Cells which have passed both positive and negative selection events and
CD8+ are maturing in the thymic medulla and acquiring a killer phenotype
CD3+
8 CD4-SP thymus CD4+ TCR ab + Cells which have passed both positive and negative selection events and
CD8- are maturing in the thymic medulla and acquiring a helper phenotype.
CD3+
9 Spl CD8 spleen CD8+ Mature peripheral killer T cells.
CD4-
TCRab +
10 Spl CD4 spleen CD4+ Mature peripheral helper T cells.
CD8-
TCRab +
11 Fetal ab FTOC TCR ab + ab T cells which developed in fetal thymic organ culture from day 14 
TCRgd - fetal thymus lobes.
12 Fetal gd FTOC TCR gd + ab T cells which developed in fetal thymic organ culture from day 14 
TCRab - fetal thymus lobes.
13 pro-B SCID B220+ IgM - Specified or committed B-lineage precursors prior to IgH rearrangement.
bone marrow CD43+
CD19+
14 pre-B bone marrow B220+ Mixture of pro-B and pre-B cells prior to IgH cell surface expression,
IgM - heavily biased towards pre-B cells due to a proliferative burst after IgH 
rearrangement.
15 B cell bone marrow B220+ Mixture of immature and mature B cells expressing IgM on the surface
IgM+
16 Myeloid bone marrow Gr-1+ Mixture of immature and mature granulocytes and macrophages.
Mac-1+
17 Spl B spleen B220+ Mature peripheral B cells, probably mostly IgM and IgG bearing B cells.
TCRab -
*Cells were obtained from mice of different genotypes to maximize purity of the desired population. For a detailed comparison of the properties of immature
thymocytes in wild-type, SCID and Rag-2- /- mice, see our previous studies (Diamond et al., 1997; Rothenberg et al., 1993). MHC-deficient mice were used as a
preferred source of DP thymocytes to ensure that cells with this phenotype could not have received any maturation signals in vivo before isolation. Wild-type DP
thymocytes and total CD4- CD8- CD3– thymocytes were also prepared and analyzed in other experiments, and gave results consistent with those of populations
from mutant animals (data not shown).
‡Purities of sorted fractions used in this work were determined by reanalysis, as follows. Pop. 0, >97%; Pop. 1, >98%; Pop. 1a, 91% (heterogeneous for Sca-1
expression); pop. 2, 97%; pop. 2a, 97%; pop. 3, >98% (but CD44 heterogeneous, only 90% CD44high); pop. 4, approx. 100%; pop. 5, >99%; pop. 6, approx.
100%; pop. 7, >97%; pop. 8, >99%; pop. 9, approx. 100%; pop. 10, approx. 100%; pop. 11, >99%; pop. 12, >99%; pop. 13, >97%; pop. 14, >98%; pop. 15, 96%;
pop. 16, approx. 100%; pop. 17, approx. 100%. 
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elements of the expression pattern that are T-lineage specific,
immature and mature B cell subsets, a putative immature NK
population, and mixed mature and immature myeloid cells
were also analyzed in parallel. In many cases, we took
advantage of mutant mouse strains to obtain certain subsets in
high purity, but in these cases population characteristics were
always verified by further analyses of the same subsets
obtained from wild-type or unrelated mutant strains. The full
derivations and phenotypes of these populations are presented
in detail in Table 2, and the fluorescence-activated cell sorting
gates used to define and isolate the developmentally early
populations are illustrated in the Appendix. Because the target
gene specificity of Erg appears to overlap substantially with
that of other Ets factors (Rivera et al., 1993; Murakami et al.,
1993; Nikolajczyk et al., 1997), the expression of eight other
Ets family transcription factor genes was monitored in parallel
with Erg. RNA was extracted from all of these sorted
populations and expression of Erg and eight additional Ets
family members (Ets-1, Ets-2, Fli-1, PU.1, Spi-B, Elf-1, Tel
and GABP a ) were assessed by RT-PCR. The domain
structures of these Ets family
transcription factors and the location of
the primers in the coding sequences of
these genes are shown in Fig. 3. 
The small numbers of cells obtained
from large sorting experiments for some
of these populations (for example,
20,000 cells from the thymuses of 20
immune-deficient mice) precludes non-
PCR-based analysis of these
populations; however, great care was
taken to ensure the reproducibility and
validity of all results reported here. The
samples were normalized to equalize
HPRT amplification products, and cycle
numbers were minimized to prevent
saturation of the PCR reaction.
Furthermore, each PCR reaction was
run at least twice, and in most cases on
equivalent samples isolated from
different sorting experiments. 
Combinatorial expression of Ets
family members in T and B cell
development
A representative set of PCR products
indicative of Ets family member
expression patterns in different stages of
lymphoid development is shown in Fig.
4. These results confirm that there are
much higher levels of Erg in purified
immature thymocytes (pops 2-4) than in
mature splenic T cells (pops 9,10), as
suggested by the differential screen
(Fig. 2). Furthermore, these results
highlight the combinatorial nature of
the Ets family factor representation in
different lymphoid lineages. While
multiple Ets family factors are expressed in every cell
population analyzed, individual Ets family factors display
distinct patterns of developmental regulation. Although Ets-1
and Elf-1 are expressed stably throughout all stages tested, and
GABPa also is expressed broadly, every other Ets factor
examined here shows at least one developmental transition at
which it defines a unique regulatory response. 
Shifts in Ets family expression define developmental
transitions in the T-cell lineage
The data shown in Fig. 4 indicate that T-lineage cells are
marked from the very earliest stages of their development by
strong and consistent expression of Fli-1, Ets-2 and GABP a in
addition to the more broadly expressed Ets-1, Elf-1 and Tel.
However, the earliest T-lineage cells undergo dramatic shifts in
the expression of three other Ets factors that mark several
regulatory transitions: Erg, PU.1 and Spi-B. These factors are
expressed in the immature T cells but are severely repressed in
all thymic T cells after the b -selection checkpoint (pop. 4 fi 5).
The transition from an uncommitted pro-T cell (Fig. 4, pop. 3)
M. K. Anderson and others
Ets-1
Ets-2
Fli-1
Erg
Elf-1
GABP a
PU.1
SpiB
ETS domain
Transactivating
Inhibitory
PEST/Pip
PEST/Pip
Ser or Ser/Thr rich
alternative splicingAlt starts
Tel
alternative splicing
Primer locations
Alt starts
II I
SCALE: 40 aa
I II
Fig. 3. Domain specificity of PCR primers for Ets factor expression analysis. PCR primers
specific for each Ets factor examined here were designed to avoid cross-reactions between
related family members. The functional domain structures of each factor are depicted by
boxes: black solid boxes indicate the ETS DNA binding domain; diamond boxes indicate
activation domains, including the Pointed (HLH) domains in Ets-1, Ets-2, Fli-1, Erg, GABPa
and Tel; blue boxes indicate serine-rich or serine-threonine rich regions (Bassuk and Leiden,
1997); and striped boxes indicate inhibitory domains. Other domains are as specifically
indicated. The location of each primer is designated by arrows underneath the boxes; in cases
where more than one primer set was used, the primer sets are indicated by roman numerals.
Two splice isoforms (Erg-2 and Erg-3) are amplified by Erg primer set I (as seen in Figs 6 and
7), while only the longest splice isoform (Erg-3), which includes all known exons, is
amplified by Erg primer set II (as seen in Fig. 4). Both Erg and Spi-B have alternative start
sites, but only the alternative start sites of Spi-B are examined here, and are amplified
differentially by Spi-B1 (I) and Spi-B2 (II) primer sets. 
to a committed pro-T cell (pop. 4) is thought to occur one stage
earlier than the b -selection checkpoint (RAG/SCID arrest
point; asterisk in Fig. 4). This event is marked by two changes
in Ets family gene expression: the downregulation of PU.1 and
the temporary upregulation of Spi-B. Once the cells pass the b
selection checkpoint, Erg and Spi-B are shut off (although
some transient low level expression from the Spi-B2 promoter
is seen in the DP cells, pop. 6), and the essentially stable T-cell
pattern of Ets factor expression is established.
Erg is also expressed in the B cell lineage in a fashion biased
strongly toward the immature cells (compare Fig. 4, pops 13, 14
versus 15). None of the other factors examined show immature
cell specificity for both the T and B lineages. Fli-1, which is
closely related to Erg, shows a different pattern of expression in
precursors of the B versus the T lineage. While Erg is shut off
in the pre-T cells (pops 5, 6) but expressed in the pre-B cells
(pops 13, 14), Fli-1 is expressed in the pre-T cells but
downregulated in the pre-B cells. In mature B cells, however,
Erg is downregulated relative to its expression in pre-B cells, and
Fli-1 is upregulated. Mature T cells continue to express Fli-1,
but do not express Erg at all in either the thymus or the spleen.
PU.1 and Spi-B (two promoter variants) are expressed, like
Erg, only at the earliest stages of T cell development. Neither
is expressed in thymocytes after the b -selection checkpoint
(although PU.1 and Spi-B1 are seen again occasionally in
samples representing mature peripheral T cells; cf. Fig. 4, pop.
10). Both are expressed throughout B cell development (Fig. 4,
pops 13-15). When examined in detail, however, it becomes
apparent that Spi-B and PU.1 are not coregulated. In agreement
with previous studies, PU.1 is expressed at very high levels in
the myeloid subset, while Spi-B is not expressed at all in these
bone-marrow derived myeloid cells (Chen et al., 1995; Su et al.,
1996). Futhermore, population 3 of immature thymocytes,
which is a rapidly proliferating population (Pénit et al., 1995),
exhibits relatively strong expression of PU.1 but low expression
of Spi-B. Spi-B expression is then sharply upregulated in
population 4 as PU.1 expression drops. At the very next stage,
which represents b -selection, in parallel with the shutoff of Erg,
Spi-B expression from promoter 1 and any residual PU.1
expression are fully extinguished. Spi-B expression from
promoter 2 is permanently silenced after the DP stage, and
doesn’t occur again even in the splenic T populations.
Several Ets factors that have been linked to normal or
malignant proliferation and activation responses (Ets-1, Ets-2,
Fli-1, Elf-1, Tel and GABP a ) show no major modulations in
expression level throughout T cell development. The stability
of this expression is surprising in view of the numerous
changes in function, proliferative capacity, sensitivity to
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Fig. 4. Ets factor expression
analysis of lymphoid
developmental subsets. RT-
PCR was performed on
normalized samples of cDNA
(see HPRT) from cells
representing 16 different
hematopoietic developmental
stages, as described in Fig. 1
and Table 2. Specific PCR
primers for the factors Ets-1,
Ets-2, Erg, Fli-1, Elf-1, Tel,
GABPa , PU.1 and two
different isoforms of Spi-B
were used to amplify products
from each sample in parallel,
which were resolved on
agarose gels. The expression
pattern of the PU.1/Spi-B
cofactor Pip/LS-IRF is also
presented here. The PCR
products shown in this matrix
are representative of the
results of multiple
experiments. The major
groupings of this profile –
pre-NK cells, postnatal
thymic subsets, fetal thymic
subsets, B cell subsets and
myeloid cells – are set aside
by white vertical bars. The
asterisk above the matrix
indicates the Rag-2- /- /SCID arrest point (corresponds in normal genotype to b -selection checkpoint). The postnatal thymic populations to the
left of this point were collected from Rag-2- /- mice, while those to the right were collected from either MHC-deficient mice (pop. 6) or normal
mice. Results from the MHC-deficient cells have been confirmed in a sorted normal CD8+CD4+ thymocyte sample. The Erg PCR products are
derived from Erg primer set II. Note that the B cell samples are slightly lower in mRNA content, according to HPRT analysis, than the other
samples. 
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apoptosis and T cell receptor signaling responses that occur
during these stages (Owen and Venkitaraman, 1996; Malissen
and Malissen, 1996; Rothenberg et al., 1994), and suggests that
these Ets factors are not essential for these changes. In general,
factors that are still expressed in the T lineage after the b -
selection checkpoint, such as Fli-1 and GABPa , show little if
any difference between TCRab and TCRgd cells, between
CD4+ helper cells and CD8+ killer cells, or between rapidly
proliferating (pops 3, 5) and resting (pops 4, 6, 9, 10) cells.
Confirmation of RT-PCR results by RNA gel blot
hybridization 
In order to confirm the expression patterns seen in the RT-PCR
experiments, two RNA gel blots were generated using total
RNA from various hematopoietic cell types (Fig. 5). The first
blot was hybridized with a probe representing the Erg-specific
domain and which does not cross-react with Fli-1. This blot
was stripped and hybridized to an Fli-1 specific probe. The
hybridization patterns of Erg and Fli-1 (Fig. 5A) support the
RT-PCR analyses. Erg is observed in the immature thymocytes
(lanes 1 and 2) and in the sample containing predominantly
myeloid cells (lane 8), but not in the samples that consist
primarily of pre-T cells (lanes 3 and 4) or mature lymphocytes
(lanes 5 and 6). Fli-1 is expressed in all of the T lineage
samples (lanes 1-4) as well as in the sample enriched in mature
T and B cells (lane 5). Fli-1 is seen in the bone marrow samples
as well, possibly due to the substantial percentage of IgM+ B
cells (cf. pop. 15; see Fig. 4) or to expression by specific
subtypes of nonlymphoid cells such as megakaryocytes (Mélet
et al., 1996). Neither Erg nor Fli-1 is expressed in the liver, in
agreement with the differential screen analysis of Erg
expression (Fig. 2).
The second blot was hybridized with a PU.1-specific probe.
The PU.1 expression pattern (Fig. 5B) confirms that although
pre-T cells and more mature thymocytes do not express this
factor, it is present in immature thymocytes, although at much
lower levels than in the bone marrow (myeloid, B),
splenocyte (B>T), or lymph node (T>B) samples. We have
also isolated a full-length PU.1 cDNA clone from the SCID
thymocyte library. Overall, these northern blots confirm the
RT-PCR results and strengthen the evidence for differential
expression of the Ets family members during hematopoietic
development.
Regulation of Ets family members during the
multipotent progenitor to T lineage transition
A key question that emerges from these analyses is whether
any Ets factors are induced in pluripotent precursors as they
undergo specification to the T lineage. While Fig. 4 clearly
shows differences between the immature pro-T cells and later
T-lineage subsets, it does not show many differences that could
be attributed to specification of pro-T cells (Fig. 4, cf. pops 1,
3). This may be because the ‘population 1a’ sample used in
Fig. 4 (pop. 1) includes some transitional cells that are
beginning to turn on definitive T-lineage genes such as preT a
and RAG-1 (Wang et al., 1998a,b) (see Fig. 1 legend and
Appendix). To obtain more pure populations of potentially
unspecified precursors (pop. 0/1), two strategies were adopted,
as shown in Fig. 6A,B. First, the multipotent progenitors (pop.
1) were sorted according to a more strict Sca-1high CD24 -
criterion than that used for Fig. 4 (pop. 1a), to purify them as
previously described (Wang et al., 1998a,b) (Fig. 6A). Second,
we made use of an additional sorting strategy to isolate a
minute subset of cells that may represent even earlier
precursors (Table 2, ‘population 0’) (Fig. 6B) (For details of
these cell separations, see Appendix). 
Comparison between these precursor populations and
reference pro-T cell populations isolated in parallel (pop. 3,4)
shows dramatic changes in the expression of several Ets factors
during the transition leading to pro-T cells. First, Erg is induced
de novo, and Spi-B2, Ets-2 and, to a lesser extent, Ets-1 also
appear to be upregulated, as cells make the transition between
population 1 and population 3. Elf-1 and PU.1 are expressed
at similar levels in both populations. Only Spi-B1 (especially
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Fig. 5. Northern blot analysis of Erg, Fli-1 and PU.1 expression in
hematopoietic tissues. Total RNA from hematopoietic cell
suspensions were resolved on denaturing agarose gels, blotted and
probed. Roughly equal loading on each blot (20 m g/lane) is indicated
by the 18 S rRNA bands stained with ethidium bromide that are
shown underneath the hybridization data. To obtain enough material
for these blots, RNA had to be extracted from unfractionated cell
populations from the indicated tissues. Approximate equivalents in
terms of mixtures of pure populations are as follows. The first blot
contains: SCID thymocytes (ST), representing immature cells of
populations 1-3; Rag-2 - / - thymocytes (RT), representing immature
cells of populations 1-4; MHC - / - thymocytes (MT), representing
>90% population 6 with 2-5% population 1-4 cells; normal
unfractionated thymocytes (NT), similar to MT except including
about 15% SP cells (populations 7 and 8); normal splenocytes (SPL)
depleted of red blood cells, representing mostly mature T and B cells
(B>T) with some myeloid cells; lymph node cells (LN), representing
mature T and B lymphocytes (T>B); SCID bone marrow (SBM),
which consists of approximately 5% pro-B cells and approximately
95% myeloid cells; normal bone marrow (NBM), with 50% myeloid
cells and 20% pre-B, immature B and mature B cells; and liver. This
blot was hybridized with an Erg-specific probe, stripped, and then
reprobed with a Fli-1 specific probe. The second blot contained the
same samples as the first with the following changes: no Rag-2 - /-
thymocytes and kidney instead of liver. The second blot was probed
with a PU.1 specific probe. 
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the putative splice isoform represented in the lower band in Fig.
6A) appears to decrease slightly between the multipotent
lymphoid progenitor and the early T lineage cells. This change
is quite reproducible between different, independently
generated samples (Fig. 6B, data not shown). 
These results are supported and extended by a limited
analysis of Ets family gene expression in ‘population 0’ as
compared to the pro-T cells (Fig. 6B). This minute population
requires more complete characterization, but about half the
cells in this population have properties that make them
important candidates to consider for the earliest of common
lymphoid progenitors in the thymus (c-kit+, IL-7R+, Thy-1neg,
IL-2R b neg, NK1.1neg, etc.; R. A. Diamond, H. Wang, C. Simion
and E. V. Rothenberg, unpublished results). In these cells (Fig.
6B, ‘prec.’; pop. 0), not only Erg but also Spi-B2 expression is
very low or undetectable, much lower than in the pro-T cells.
By contrast, Elf-1 and Ets-1 appear to be expressed in the
precursors at similar levels to those in the pro-T cells. The data
also suggest that PU.1 and Spi-B1 are expressed at much
higher levels in the population 0 cells than in the pro-T cells
(Fig. 6B), but the relevance of these findings awaits a
population 0 sample known to be homogeneous for lymphoid
precursor activity.
These results indicate that while expression of PU.1 and Spi-
B1 may be ‘inherited’ from a pluripotent precursor, expression
of Erg (and perhaps Spi-B2 as well) is specifically induced as
cells make the transition to the pro-T cell stage. Even so,
expression of all three of these genes is severely and lastingly
repressed once the cells pass through the b -selection
checkpoint (with the exception of Spi-B2, transiently
downregulated after b selection, and then permanently shut off
at checkpoint 2). Thus, these results distinguish pro-T cells,
even after specification and to some extent after commitment,
from all preceding and subsequent stages of T cell
development.
Unique pattern of Ets factor expression in pre-NK
cells
The pre-NK cells found among SCID and RAG-2 - / -
thymocytes (pops 2, 2a) strongly express IL-2R b (CD122),
and the lytic protein perforin (Diamond et al., 1997; Wang et
al., 1998b), both of which are known to be Ets factor targets.
Our results indicate that these cells express Ets-1, Fli-1,
GABP a and Elf-1, and modest levels of Tel and Ets-2 (Figs
4, 6). However, they either turn off or fail to turn on Erg, PU.1
and Spi-B. To the extent that thymic pre-NK cells appear to
express PU.1 or Spi-B at all (data not shown), it may be a
result of contamination with ‘population 0’ cells, which can
be present as an approximately 10-20% minority in this
population if not specifically excluded by use of the Thy-1
marker (see Table 2). Direct comparison (Fig. 6B) shows that
neither PU.1, Spi-B1, Spi-B2 nor Erg is expressed at all in the
pre-NK cells, when they are purified away from the population
0 cells. 
A distinctive Ets family regulation program in B-cell
development
We have confirmed and extended the Ets factor expression
patterns in B-lineage cells seen in Fig. 4 by analyzing several
additional B-lineage samples for Ets-1, Ets-2, Erg, Fli-1 and
PU.1 expression, as shown in Fig. 7A. Here, independently
isolated samples representing pro-B cells (pop. 13) and fully
mature peripheral B cells (pop. 17; see Table 2) are compared
with a DN (double negative; CD4- CD8 - ) thymocyte sample
sorted from normal thymus (pops 1-4 and cells in the
transition from 4 to 5) as a reference for comparison to the T
cell subsets in Fig. 4. Direct comparisons of this DN
thymocyte sample with the pro-T1 and pro-T2 populations
sorted from Rag-2 - / - thymus do not show appreciable
differences in Ets-1, Ets-2, Erg, or Fli-1 expression levels
(data not shown). Higher PCR cycle numbers were used in
Fig. 7A to achieve greater sensitivity of detection than in Fig.
4. Fig. 7A shows clearly that PU.1, Fli-1 and Ets-2 are all
upregulated at a late stage during B cell maturation, while Erg
is downregulated. Fli-1 and Ets-2 are expressed at low levels
in pro-B cells as compared to the immature thymocytes, while
PU.1 is expressed in all B cell subsets at higher levels than
seen in the DN thymocyte sample (this population normally
contains <20% of cells in pops 1-3). 
The Ets family gene expression program in early B-lineage
cells resembles that in pro-T cells in some respects, including
the expression of Erg and PU.1. Although some primitive cells
in the thymus preserve B-lineage developmental capability (see
Fig. 1), the Erg and PU.1 expression in the precursor-like and
pro-T populations is not a result of contamination with
determined B-lineage precursors. First, the pro-T1 cells, which
Table 3. ETS factor target genes expressed during lymphocyte development
Population
Genes 2 1 3 4 5 ProB PreB B
TCR-Cb + + + + + + + –
TCRa – – – – + – nd (–) nd (–)
TdT – -/+ + ++ + + – –
IL-2R a – – + + – – + –
IL-2R b + – – – – – – –
Perforin ++ + – – – – – –
Ig m – + – – nd + + +
M-CSF-R – + – – nd nd nd nd
The data presented in this table are a compilation of results from our laboratory and from other studies, as reviewed in Bassuk and Leidin (1997).
nd, not determined.
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express both factors, do not show B-cell precursor activity
(reviewed by Shortman and Wu, 1996; Zúñiga-Pflücker and
Lenardo, 1996). Second, in a more direct assay, we have
determined that the levels of Erg and PU.1 in purified pro-T
cells exceed those that could be attributed to contamination
with B cell precursors. These results are shown in Fig. 7B.
Using sorted DP pre-T cell cDNA as a base lacking Erg or PU.1
expression (Fig. 7B, lane 2), we have mixed pro-B cell cDNA
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Fig. 6. Induction of specific Ets factors in putative thymic
precursor subsets. (A) RT-PCR was performed on thymic
subsets isolated from Rag-2 - /- mice based on expression
of Sca-1 and HSA. Population 1 is Sca-1+HSA- sorted on
a narrow gate, and consists of putative multipotent
precursors. The second population is Sca-1+HSA+ (pop.
3,4), and consists of a mixture of cells which are either
specified or committed to the T lineage prior to TCR
rearrangement; in the Rag-2 - / - , this population is heavily
biased towards population 4 rather than population 3
(Diamond et al., 1997). For details of cell separation see
Appendix, panel A. (B) RT-PCR also was performed on
thymic subsets isolated from B6 SCID mice based on
expression of Sca-1, HSA and Thy-1. Population 0
consists of Sca-1 - HSA- Thy-1 - thymocytes, and is
another putative multipotent precursor population.
Population 2a consists of Sca-1 - HSA- Thy-1+
thymocytes, and represents the NK cell precursors. This
population is designated 2a to distinguish it from
population 2 as seen in Fig. 4, which is a mixture of
populations 2a and 0, although heavily skewed towards
population 2. The third population (3,4) is Sca-
1+HSA+Thy-1+, and consists of a mixture of cells which
are either specified or committed to the T lineage prior to
TCR rearrangement. This population in the B6 SCID
mice, however, is heavily biased towards population 3
rather than population 4 (Diamond et al., 1997). For details of cell separation, see Appendix, panel B. The PCR products shown for each primer
set (PU.1, Spi-B1, Spi-B2, Ets-1, Erg, Elf-1 and HPRT) are representative of multiple experiments. 
A BFig. 7. Divergent regulation of Ets family
members in B cell development. (A) RT-PCR was
performed on samples separate from those
exhibited in Fig. 4 in order to further characterize
the B cell developmental regulation of Ets family
members. The DN-T sample (denoted pop. 3,4)
was obtained by sorting CD4 - CD8- CD3-
thymocytes from normal mice, and contains all of
the precursor and pro-T populations in the thymus;
however, the bulk of these cells have already
committed to the T lineage (pop. 4). The pro-B
cell sample (which is roughly equivalent to pop.
13) was obtained from Rag-2- /- mice, and the
third population represents B cells from normal
spleen, based on expression of B220 but not
TCR ab . These cells are primarily IgM-bearing
mature B cells. The likely developmental
relationships between these cells are depicted
below the PCR product results; the CLP (common
lymphoid precursor) is included for this purpose
but has not been isolated in these experiments. The
samples are normalized to HPRT as shown.
(B) RT-PCR mixing experiment. RT-PCR was
performed on cDNA from DP cells (pop. 6) mixed with B6 SCID pro-B cDNA (pop. 13) at ratios of 99:1, 95:5 and 80:20 to determine whether
the signals seen in the SCID thymocyte populations could be due to contamination with pro-B cells. These reactions were run in parallel with
reactions using cDNA from a sorted SCID thymocyte sample representing population 3, from a sorted DP sample without any pro-B cell cDNA
added, and from a sorted B6 SCID pro-B sample. PCR reactions were as for Fig. 7A, using the PU.1, ERG and HPRT primers. The mb-1
primers were used as a measure of a B cell specific transcript known to be expressed in pro-B cells but in neither SCID thymocytes nor DP
thymocytes (Wang et al., 1998a). Lane 1 (numbered from the left): B6-SCID thymocyte cDNA, Sca-1+ HSA+ Thy-1+ (pop. 3); lane 2: MHC - /-
thymocyte cDNA, CD4+ CD8+ (pop. 6); lane 3: 99:1 ratio of DP thymocyte cDNA to B6 SCID pro-B cell cDNA; lane 4: 95:5 ratio of DP-
T:pro-B; lane 5: 80:20 ratio of DP-T:pro-B; lane 6: B6-SCID B220+ CD19+ pro-B cell cDNA (pop. 13). 
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from SCID bone marrow (lane 6) with DP cDNA at ratios from
1-20% of the total (lanes 3-5), and compared the resulting
yields of Erg and PU.1 cDNA with those from purified pro-T1
cells (lane 1). An internal standard of mb-1 (Ig- a , CD79a)
cDNA, which is B cell specific (Wang et al., 1998a), shows
that the level of contamination of the pro-T cells with B lineage
precursors even as immature as these pro-B cells is below 1%,
in agreement with the high purity of these fractions as
measured by flow cytometry (see legend to Table 2). However,
the expression of Erg and PU.1 in the pro-T cells exceeds the
level observed with deliberate contamination levels of 5% or
20%, respectively. Thus the expression of Erg and PU.1 is
truly common to precursors in both the B cell and the T cell
developmental programs.
PU.1/Spi-B cofactor regulation in T and B cell
development
PU.1 and Spi-B are known to interact with the lymphocyte-
specific IRF (interferon-response factor) transcription factor
family member PIP (PU.1 interaction partner)/LS-IRF (IRF4,
NF-EM5). This factor functions as a
potent transcriptional coactivator on
Ig gene enhancers (Eisenbeis et al.,
1995; Su et al., 1996) but is not
required for PU.1 activation of
myeloid target genes. To ascertain
whether this partner is available in
all the lymphoid subsets that
express PU.1 or Spi-B, we
examined these subsets for PIP
expression as well, as shown in Fig.
4. Our PIP-specific primers amplify
two products; the upper band is the
expected size. The possibility that
the lower band represents an
alternatively spliced form is
currently under investigation. Our
results show that in the B-lineage
cells, PIP is coexpressed with both
PU.1 and Spi-B. As expected, it is
not seen in the myeloid subset
examined here. Interestingly, PIP is
also absent from the immature
thymocyte subsets where PU.1 and
Spi-B are expressed, but present in
the pre-T (pops 5, 6) and mature SP
thymocytes (pops 7-11), which lack
PU.1 and Spi-B. This suggests that
PU.1 and Spi-B may have different
roles in the immature thymocytes
than in developing B cells.
DISCUSSION
These experiments demonstrate that
Ets family transcription factor genes
are targets of intricate, lineage-
specific developmental regulation during the specification,
commitment and differentiation of various classes of
lymphocytes. Erg, Spi-B, PU.1, Fli-1 and, to a lesser extent,
Ets-2 are each subject to a different program of positive and
negative regulation in various stages of lymphoid development.
Fig. 8 provides a summary of the expression patterns of each
of these factors as a function of lymphocyte differentiation.
Thus, the regulatory regions of multiple Ets family genes are
differential targets of the regulators that confer cell-type
identity on developing lymphocytes. 
As summarised explicitly in Fig. 8, the points of inflection
in Ets family gene regulation reveal a particularly dynamic
period early in T cell development, a unique sequence of stages
when three genes are active (Erg, Spi-B and PU.1) that are not
expressed significantly at any later stage of T cell development.
This period includes the onset of expression of multiple T
lineage effector genes (i.e. T lineage specification); the loss of
developmental plasticity (commitment); and the onset of TCR
gene rearrangement. This regulatory phase ends when the cells
succeed in passing the b -selection checkpoint, and after this
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13 14 15,17
ETS-2
 PU.1
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pre-NK
  thymic
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pro-T1 pro-T2 pre-T
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Elf-1
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GABPa
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Ets-1
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ErgPU.1
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PU.1
Ets-2
Fli-1
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Fig. 8. Summary of Ets factor regulation during lymphoid specification and commitment. A
diagrammatic representation of the modulation of Ets factor mRNA expression throughout various
stages of B cell, T cell and NK cell differentiation. The white circles represent the isolated
populations according to the same numbering scheme used throughout this paper, and arrows
indicate developmental progression. The white circle without a number followed by a dashed arrow
(bottom left) refers to a hypothetical pro-B1 population which is specified but not yet committed to
the B lineage, analogous to the pro-T1 lineage, since the precise timing of B-lineage commitment
is not well resolved. The large black arrow pointing down (top left) indicates a decrease in the
factor indicated for the precursor to pre-NK cell transition. The presence or absence of different Ets
factors at each stage as monitored by relatively low PCR cycle number is depicted by colored bars,
with each color representing a different Ets factor, for the T cell developmental stages (upper half
of figure) and the B cell developmental stages (lower half of figure). Pip, an IRF transcription
factor family member and cofactor for PU.1 and Spi-B, is also depicted. The two isoforms of Spi-B
are not separated here for simplicity, but do show some differences in expression in the earliest T
cell stages (see text and Fig. 6).
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checkpoint there are no significant changes in the expression
of the Ets factors monitored here. One of the important new
findings of this work is the identification of a small set of
transcriptional regulators that are expressed specifically during
this important period of cell fate determination. Two specific
changes in expression of these factors – the onset of Erg
expression, and the shutoff of PU.1 expression – respectively
mark the specification and lineage commitment events for T
cell precursors.
More limited data on Ets gene expression have been
available previously (Prasad et al., 1994; Chen et al., 1995;
Su et al., 1996; Ford et al., 1996; Bassuk and Leiden, 1997;
Lenny et al., 1997; Nikolajczyk et al., 1997), but this is the
first time that purified populations of primary lymphocytes at
successive stages of differentiation have been compared in
detail. To the extent that previous work has considered these
cell types, the results have been generally consistent with ours
(Bassuk and Leiden, 1997; Nikolajczyk et al., 1997; Lenny
et al., 1997; Su et al., 1996). On the other hand, in previous
studies the conclusion of T- or B-lineage specificity has often
been based on analyses of immortal, malignantly transformed
cell lines. Such lines, especially the T cell lines used, bear a
very doubtful relationship to any natural stages of T cell
development. Even if Ets expression were not perturbed
during the establishment of the cell line, it would be
important to know the stage at which cells were
immortalized, because our results show substantial changes
in the expression of certain Ets genes in the course of T  and
B cell development, not a fixed ‘lineage-specific’ expression
pattern. Thus, the absence of a factor like Erg from certain T
cell lines (Rivera et al., 1993) does not preclude its playing
an important role in early stages of differentiation in primary
T cells.
Ets factor expression during T cell specification and
commitment
The distinction between the Ets factor expression profiles in
‘early’ and ‘late’ stages of T- and B-cell development is one
of the most important results from our work. The ‘early’
phase of Ets family gene expression ends just when the
thymocytes undergo a major physiological change
(Rothenberg et al., 1994), as they enter a period when their
fate becomes dependent on signaling through their T-cell
receptor complexes. It is striking that Ets family gene
expression is stable thereafter. Although there are numerous
substantial differences in activation physiology and
functional competence between cells in the DP thymocyte
population (pop. 6) and SP thymocytes (pops 7, 8) and
peripheral T cells (pops 9, 10) (Rothenberg, 1992;
Rothenberg et al., 1994; Simon et al., 1996; Rincon and
Flavell, 1996; Vanhecke et al., 1995; Kishimoto and Sprent,
1997), these cell types express complements of Ets factors
that are much more similar to each other than to the Ets
factors expressed before b -selection (pops 1, 3, 4). The
dynamic and distinctive Ets family gene regulation in ‘early-
stage’ T cell precursors therefore reflects regulatory events
that are qualitatively distinct from the life/death selection
pressures that act on thymocytes later. We propose that the
‘early’ Ets family gene expression changes are a response to
the process that narrows the developmental potential of the
pluripotent precursor, to culminate in lineage commitment.
Something of the nature of this process is revealed by the
transience of ‘early’ Ets gene expression. The sharp onset of
Erg expression around the time of the specification event(s)
gives evidence for a discrete regulatory event at the
beginning of this critical period. This is when we have found
that multiple T-lineage specific target genes are upregulated
or begin to be expressed (Wang et al., 1998a,b). Because the
cells in ‘population 0’ do not appear to express Spi-B from
the Spi-B2 promoter, it is possible that activation of this
promoter is also associated with some aspect of T-lineage
specification (cf. ‘ragged’ onset of T lineage gene expression
in Wang et al., 1998a,b). But neither Erg nor Spi-B2
induction represents the acquisition of a mature T cell
property, since both Erg and Spi-B will be shut off soon after
lineage commitment, long before T cell maturation is
complete, while T-lineage specific gene expression
continues. What kind of function could their transient
expression confer?
Work to answer this question is now underway, but it is
worth noting one speculative possibility for the role of Erg
during early T and B cell differentiation. The Ets family
members bind to DNA and transactivate transcription as
monomers. However, Erg is among a number of Ets family
members that can hetero- and homodimerize, and this is
thought to lead to an inability to bind DNA (Carrère et al.,
1998; Kwiatkowski et al., 1998). Thus, although Erg is
normally a trans-activator with growth-stimulating
properties (Hart et al., 1995; Duterque-Coquillaud et al.,
1993; Rivera et al., 1993), it is conceivable that in cells
undergoing lineage commitment, Erg could act as a stage-
specific inhibitor of transactivation by certain other Ets
family members. This type of inhibition may provide a
mechanism for maintaining developmental plasticity,
analogous to the role of Id in bHLH-mediated development
(Bain and Murre, 1998). 
The shutoff of PU.1 expression coincides remarkably well
with the transition at which commitment occurs (Figs 1, 8).
This result is exciting because PU.1 is known to be essential
for development of cells in two alternative lineages, myeloid
and B, and its activity is directly implicated in the expression
of macrophage and B cell target genes (Tenen et al., 1997;
Scott et al., 1994, 1997; McKercher et al., 1996; Olson et al.,
1995; Fitzsimmons and Hagman, 1996; Reya and Grosschedl,
1998). As long as it is present, PU.1 may preserve the ability
to express such non-T genes. Alternatively, PU.1 could
maintain some viability or growth-control property inherited
from the hematopoietic stem cell (Voso et al., 1994; Scott et
al., 1994; Anderson et al., 1998) through the early stages of T-
lineage differentiation, perhaps associated with expression of
the stem cell factor receptor c-kit (Table 2; also see Diamond
et al., 1997). PU.1 mutant mice have a severe defect in T cell
development as well as in macrophage and B cell development
(Scott et al., 1994; McKercher et al., 1996), and our discovery
that PU.1 expression extends into early stages of T cell
development suggests that an essential activity of PU.1 may
M. K. Anderson and others
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continue for a short time even after T lineage specification, as
opposed to being needed only in common precursors of these
cells.
Distinct regulatory programs for NK lineage
expression of Ets family genes
NK cells are close relatives of T cells, but the generation of
the NK-like ‘pre-NK cells’ is associated with a loss of several
Ets factors (for properties of these cells, see Diamond et al.,
1997; Carlyle et al., 1997; Wang et al., 1998b). Interestingly,
a similar loss of specific class A bHLH factors is seen in the
pre-NK cells as well (M. Anderson and E. Rothenberg,
unpublished). If they truly share common precursors with T
cells (i.e. population 1), as is generally believed, then these
cells must not only lose expression of Spi-B and PU.1
entirely, but also downregulate Ets-2 and Tel. The trigger for
these changes is unknown. Pre-NK cells do express the
known Ets target genes perforin (Zhang and Lichtenheld,
1997) and CD122 (Lin et al., 1993) (see Table 3), presumably
by using Ets-1, Fli-1, Elf-1 or GABP a (Diamond et al., 1997;
Wang et al., 1998b). The impression that they may be
relatively Ets-deficient is strengthened by the report that Ets-
1 - / - mice exhibit quasi-normal hematopoietic development
with the exception of the NK cells, which are severely
deficient (Barton et al., 1998). Thus, T and B cells in these
animals may have compensating Ets factors that are absent in
the NK cells. 
Ets factors as upstream regulators and downstream
targets
These findings provide a starting point for investigating how
the changing combinations of Ets factors in cells may affect
their expression of lymphoid-specific Ets target genes
(Bassuk and Leiden, 1997). A great variety of genes that are
differentially regulated during T cell and B cell development
are targets of regulation by Ets family genes, as illustrated by
the examples in Table 3. In many cases, in vitro binding and
transactivation assays have suggested that Ets family factors
play promiscuous and redundant roles in gene expression
(Bassuk and Leiden, 1997). Ets-1 gene knockout phenotypes
also show that some genes regulated by Ets-1 in vitro can be
regulated by other factors in vivo (Muthusamy et al., 1995;
Bories et al., 1995). In vitro, the ability of the Ets-1 factor to
drive expression of disparately regulated genes has often
made the Ets family role in gene expression appear to be
merely a ‘scaffolding function’, facilitating interaction with
other proteins (Crépieux et al., 1994), without any
developmental information content. Thus, in this context, the
strikingly precise and dramatic regulation of different Ets
family members in successive stages of lymphocyte
development that we see comes as a surprise. A similar Ets-
family factor specificity may be exercised in certain
developing neurons (Lin et al., 1998). These results are a
reminder that at least in the regulatory milieu of cells at
critical transition points, various Ets family members are
unlikely to be equivalent. 
Many of the Ets factors themselves are targets of auto- and
cross-regulation, resulting in complex regulatory networks of
multiple family members. It may be, in systems like this, that
the relative levels of the factors are critical to stabilize the
resulting gene expression patterns, so that even slight
elevations of one competing factor over another can tip the
balance, leading to a progressive downregulation of one factor
and upregulation of another (Cross and Enver, 1997;
Rothenberg et al., 1999). The downregulation of specific
subsets of Ets factors in each lymphoid cell type after
commitment (Ets-2, Spi-B and PU.1 in NK cells; Erg, PU.1
and Spi-B in T cells; and Erg in B cells) might be the result of
such a mechanism. Such scenarios remain to be tested in our
system. 
The impact of individual Ets factors on the steps of the
lymphoid differentiation process can now be tested rationally
by perturbation studies. The work presented here indicates
three strategic considerations that would not have been
evident before. First, Erg, Spi-B and PU.1 – factors not
previously considered in the context of T-lineage
differentiation – should be tested for specific positive roles in
precursor expansion and/or T-lineage specification, early in T
cell development. Second, by contrast, multiple Ets factors
expressed by mature T cells become less attractive candidates
for individual perturbation, since they show so little
developmental inflection in their own expression that they
may simply constitute a stable and/or redundant pool of
generalized Ets function for T-lineage cells. Finally, the
extinction of Erg, Spi-B and PU.1 expression at the b -
selection checkpoint raises the possibility that continued
expression of these factors would be incompatible either
with stabilization of T cell lineage identity or with the
physiology of T-cell-receptor-dependent repertoire selection.
Accordingly, studies to test the impact of the forced
expression of these factors are now in progress.
In summary, the major developmental stages of T and B
cell differentiation are defined by expression of overlapping
but distinct combinations of Ets family members. Erg is
sharply upregulated in T cell precursors at the time of
specification to the T lineage. It remains to be seen whether
Erg has a role in activating the T cell gene expression
program or in destabilizing alternative, precursor gene
expression states. The silencing of Erg, PU.1 and Spi-B just
after commitment to the T lineage could be as important in
T cell development as their activation, especially since PU.1
and Spi-B are already expressed at low levels in the earliest
thymocyte precursors. Furthermore, the precise and unique
timing of PU.1 downregulation suggests an essential
relevance to T-lineage commitment. The link between these
combinations of Ets family members and potential
downstream target genes remains to be studied. The results
presented here, though, at least predict that the promoter and
enhancer elements of these Ets factors will themselves be
highly specialized targets of developmentally specific
regulators. In future work, combined approaches integrating
upstream and downstream targets of the Ets factors should
yield a wealth of insight into the transcription factor
networks which establish and maintain the lymphoid
lineages.
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APPENDIX 
Flow cytometry sorting gates used to collect the populations
examined in (A) Fig. 4, (B) Fig. 6B, (C) Fig. 6A and (D) Fig.
7. Colors and numbers are consistent with all other figures and
tables. Note the difference in sorting gates between pops 1a
(A) and 1 (C) and pops 2a (B) and 2 (A). Pop. 1 is indicated
in (B) but low cell numbers prohibited collection of all four
populations from this sample. 
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